All clear for the decisive trial of ecstasy in PTSD patients

Chat & Introductions
1

Interesting – Ecstasy (MDMA) is seeing some renewed interest by the FDA. Hopefully we’ll see some of that interest in cannabis soon as well.

3 Likes
2

Remind me of this study from 2004-2008 where they treated cancer patients with Psilocybin. Cannot believe this passed an ethics committee, but since it did, it speaks volumes of those conducting the research

3 Likes
3

This is pretty exciting! The FDA is fast tracking the research and working with MAPS during the phase III clinical trial. I read here that they hope to have MDMA available for PTSD treatment by 2021.

3 Likes